Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Nexalin Technology Inc NXL

Nexalin Technology, Inc. is engaged in designing and developing neurostimulation products for the mental health epidemic. The Company has developed an easy-to-administer medical device (Generation 1 or Gen-1) that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Current News (NDAQ:NXL)

New Peer-Reviewed Publication Validates Nexalin's Deep Intracranial Frequency Stimulation (DIFS) Technology, Reinforcing Leadership in High-Growth Neuromodulation Market

GlobeNewswire 4 hours ago

Nexalin Technology CEO Provides Letter to Shareholders

GlobeNewswire November 11, 2024

Join Nexalin Technology's Exclusive Live Investor Webinar and Q&A Session on November 5th

GlobeNewswire November 1, 2024

Nexalin Technology Regains Compliance with Nasdaq Continued Listing Requirements

GlobeNewswire November 1, 2024

LOBO EV and Nexalin Technology Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

Accesswire November 1, 2024

Nexalin Technology Announces Landmark Study on Alzheimer's Disease and Deep Intracranial Frequency Stimulation Published in Journal of Alzheimer's Disease

GlobeNewswire October 28, 2024

Nexalin Technology and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

Accesswire October 25, 2024

Nexalin Technology Announces Planned Clinical Trial Utilizing Gen-3 Halo Headset in Partnership with UC San Diego & San Diego VA

GlobeNewswire October 22, 2024

New Study Shows Nexalin's Deep Intracranial Frequency Stimulation (DIFS) Significantly Improves Memory and Cognitive Function in Alzheimer's Patients

GlobeNewswire October 17, 2024

Opinion & Analysis (NDAQ:NXL)

No current opinion is available.

Bullboard Posts (NDAQ:NXL)

Nexalin Technology, Inc. (NXL): Innovative Neurostimulation

http://beyondspx.com/2024/08/01/nexalin-technology-inc-nxl-innovative-neurostimulation-solutions-poised-for-growth/
MikeTester - August 2, 2024

BUY BUY BUY BUY BUY

Next multi bagger
Nibinator - June 22, 2024

NXL..... I was wrong

Lo Siento !!!!!
Iseneschal - June 21, 2024

NXL.....After all....it is "Fryday"

sec.gov/Archives/edgar/data/1527352/000182912624003705/nexalintech_s1.htm
Iseneschal - June 21, 2024

NXL..... Go ahead.....I dare ya

P.O set up Wait for the announcement
Iseneschal - June 21, 2024

Boom

eom
Cobalt - June 21, 2024